niclosamide has been researched along with Infections, Respiratory Syncytial Virus in 2 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, J | 1 |
| Wu, W | 1 |
| Chen, H | 1 |
| Xue, Y | 1 |
| Bao, X | 1 |
| Zhou, J | 1 |
| Niyomdecha, N | 1 |
| Suptawiwat, O | 1 |
| Boonarkart, C | 1 |
| Thitithanyanont, A | 1 |
| Auewarakul, P | 1 |
2 other studies available for niclosamide and Infections, Respiratory Syncytial Virus
| Article | Year |
|---|---|
Substituted N-(4-amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide analogues potently inhibit respiratory syncytial virus (RSV) replication and RSV infection-associated inflammatory responses.
Topics: A549 Cells; Antiviral Agents; Benzamides; Humans; Inflammation; Respiratory Syncytial Virus Infectio | 2021 |
Repurposing of antiparasitic niclosamide to inhibit respiratory syncytial virus (RSV) replication.
Topics: Antiparasitic Agents; Antiviral Agents; Drug Repositioning; Humans; Mechanistic Target of Rapamycin | 2021 |